Personalized Risk Stratification in Colon Cancer using Radiomic-Based Predictive Models
Collado, M.; Castillo, M. E.; Larriba, M. J.; Galindo-Pumarino, C.; Flores, C.-L.; Ferreiro, R.; Canales, E.; Garcia, R.; Avendano-Ortiz, J.; Gonzalez-Sancho, J. M.; de la Pinta, C.; Pena, C.
Show abstract
Colon Cancer (CC) is among the most frequently diagnosed malignancies and a leading cause of cancer-related death worldwide. Five-year survival varies markedly by stage at diagnosis, underscoring the need for precise risk stratification. Otherwise, although stage III CC patients routinely receive adjuvant chemotherapy, some exhibit a low risk of recurrence and could safely undergo shorter regimens. Conversely, a subset of stage II patients faces a higher relapse risk and may benefit from intensified treatment. In this context, radiomics has emerged as a cutting-edge, non-invasive approach capable of extracting quantitative information from routine medical imaging to support clinical decision-making. We aimed to develop radiomic-based machine learning models able to distinguish stage II from stage III CC patients while identifying individuals at increased risk of 5-year relapse. A cohort of 104 patients who underwent preoperative computed tomography was analyzed by 3D tumor segmentation. Thus, 105 radiomic features and preoperative clinical variables were extracted. Predictive models were trained and validated employing a 70/30 split and 10-fold cross-validation. The Generalized Linear Model achieved the best performance for stage differentiation (AUC=0.760). For 5-year relapse prediction, the Partial Least Squares model showed excellent performance (AUC=0.910), outperforming the Support Vector Machine model (AUC=0.730). Subgroup analyses confirmed strong predictive capacity when evaluating stage II (AUC=0.929) and stage III patients (AUC=0.926) separately. To our knowledge, this is among the first studies demonstrating that radiomics can simultaneously stratify CC stage and predict relapse risk with high accuracy, highlighting its potential as a powerful tool to guide personalized treatment strategies. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=166 SRC="FIGDIR/small/25341095v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@ef96org.highwire.dtl.DTLVardef@17185c8org.highwire.dtl.DTLVardef@628e1org.highwire.dtl.DTLVardef@65e468_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Use of high-plex data reveals novel insights into the tumour microenvironment of clear cell renal cell carcinoma 94%
- Prediction of radiation-induced hypothyroidism using radiomic data analysis does not show superiority over standard normal tissue complication models 93%
- NDRG1 expression is an independent prognostic factor in inflammatory breast cancer 92%
Similar papers in this journal
- Computational analysis of pathological image enables interpretable prediction for microsatellite instability 92%
- Predicting Axillary Lymph Node Metastasis in Early Breast Cancer Using Deep Learning on Primary Tumor Biopsy Slides 92%
- Diagnostic accuracy and safety of coaxial core-needle biopsy (CNB) system in Oncology patients treated in a specialist cancer centre with prospective validation within clinical trial data 92%
Similar papers in this journal
- Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling 92%
- Non-B DNA-Informed Mutation Burden as a Marker of Treatment Response and Outcome in Cancer 91%
- A prospective validation of nomograms based on BC-116 and BC-106 urine peptide biomarker panels for bladder cancer diagnostics and monitoring 90%
Similar papers in this journal
- Comparison of Radiomic Feature Aggregation Methods for Patients with Multiple Tumors 93%
- Predicting Prognosis and IDH Mutation Status for Patients with Lower-Grade Gliomas Using Whole Slide Images 92%
- Identifying relationships between imaging phenotypes and lung cancer-related mutation status: EGFR and KRAS 92%
Similar papers in this journal
- Radiomic-Based Approaches in the Multi-metastatic Setting: A Quantitative Review 94%
- Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer 92%
- Inference of core needle biopsy whole slide images requiring definitive therapy for prostate cancer 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.